We investigated the antidepressant effect of creatine (CRE) and taurine (TAU) mixtures on behavioural changes and biomarkers in stress-induced depression in Drosophila melanogaster and a mouse model. Following CRE/TAU mixture administration in the Drosophila model, depression-like state induced by vibration, locomotion, climbing activity, and survival rate were measured. The normal stress (NS) group demonstrated decreased movement than the control (CON) group; movements in the CRE/TAUtreated group (particularly 0.15/0.5%) returned to the CON levels. Antidepressant effects of CRE/TAU mixtures were confirmed in a depressive mouse model induced by chronic mild stress. In behavioural assessments, movement and sucrose preference of the CRE/TAU group increased to a similar level as in the positive control group; hippocampal catecholamine and serotonin levels increased significantly. Stress-related hormones (adrenocorticotropic and corticotropin-releasing hormones) and inflammatory factors (IL-1β, IL-6, and TNF-α) increased in the NS group but significantly decreased in the CRE/TAU-treated group. Brain signalling protein expression ratio of phosphorylated protein kinase B (p-Akt)/Akt, phosphorylated extracellular signal-regulated kinase (p-ERK)/ERK, and brain-derived neurotrophic factor (BDNF) significantly increased in the CRE/TAU-treated group. These results indicate that CRE/TAU-induced antidepressant effects are associated with increased behavioural patterns and downregulation of stress hormones and cytokines, mediated through Akt and ERK/BDNF pathways in vertebrate models. Depression, commonly known to render a person's mental state or physical activity incapacitated, is classified as one of the most dangerous diseases in modern society according to the World Health Organization (WHO), with a prevalence of 15-25% of the world's population 1,2. The etiology of depression remains unclear; however, biological, genetic, and social psychological factors are thought to interact with each other 3,4. Currently, most patients with depression are treated with synthetic drugs, including selective serotonin reuptake inhibitors (SSRI), serotonin-norepinephrine reuptake inhibitors, tricyclic antidepressants, norepinephrine and dopamine reuptake blockers, and monoamine oxidase inhibitors 5. However, these chemically synthesised antidepressants have low reactivity and recovery rates and have side effects such as fatigue, sleep disorders, cognitive disorders, and sexual dysfunctions 6,7. Therefore, several studies have recently been undertaken owing to the increased demand for naturally derived antidepressants from medicinal plants and food-containing ingredients. The important physiological role of creatine (CRE) in depression has been confirmed in several clinical studies 8-10. Reportedly, there is a decrease in phosphocreatine in the brains of severely depressed patients 8. In particular, CRE supplements improve the mood of individuals with post-traumatic stress disorder, depression, fibromyalgia 9 , and therapy-resistant depres...